搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Burkholderia cenocepacia ATP-dependent dethiobiotin synthetase BioD (bioD) CSB-YP539890BXQ
CSB-EP539890BXQ
CSB-BP539890BXQ
CSB-MP539890BXQ
CSB-EP539890BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia tRNA 2-thiocytidine biosynthesis protein TtcA (ttcA) CSB-YP539891BXQ
CSB-EP539891BXQ
CSB-BP539891BXQ
CSB-MP539891BXQ
CSB-EP539891BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia S-adenosylmethionine synthase (metK) CSB-YP539892BXQ
CSB-EP539892BXQ
CSB-BP539892BXQ
CSB-MP539892BXQ
CSB-EP539892BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP539893BXQ
CSB-EP539893BXQ
CSB-BP539893BXQ
CSB-MP539893BXQ
CSB-EP539893BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia tRNA modification GTPase MnmE (mnmE) CSB-YP539894BXQ
CSB-EP539894BXQ
CSB-BP539894BXQ
CSB-MP539894BXQ
CSB-EP539894BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Putative pterin-4-alpha-carbinolamine dehydratase (Bcenmc03_0095) CSB-YP539895BXQ
CSB-EP539895BXQ
CSB-BP539895BXQ
CSB-MP539895BXQ
CSB-EP539895BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Tryptophan synthase alpha chain (trpA) CSB-YP539896BXQ
CSB-EP539896BXQ
CSB-BP539896BXQ
CSB-MP539896BXQ
CSB-EP539896BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Selenide, water dikinase (selD) CSB-YP539897BXQ
CSB-EP539897BXQ
CSB-BP539897BXQ
CSB-MP539897BXQ
CSB-EP539897BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia NH (3)-dependent NAD (+) synthetase CSB-YP539898BXQ
CSB-EP539898BXQ
CSB-BP539898BXQ
CSB-MP539898BXQ
CSB-EP539898BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia UPF0145 protein Bcenmc03_5217 (Bcenmc03_5217) CSB-YP539899BXQ
CSB-EP539899BXQ
CSB-BP539899BXQ
CSB-MP539899BXQ
CSB-EP539899BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia L-rhamnose mutarotase (rhaM) CSB-YP539900BXQ
CSB-EP539900BXQ
CSB-BP539900BXQ
CSB-MP539900BXQ
CSB-EP539900BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Deoxyribose-phosphate aldolase (deoC) CSB-YP539901BXQ
CSB-EP539901BXQ
CSB-BP539901BXQ
CSB-MP539901BXQ
CSB-EP539901BXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella woodyi Coproporphyrinogen-III oxidase, aerobic (hemF) CSB-YP539902SYY
CSB-EP539902SYY
CSB-BP539902SYY
CSB-MP539902SYY
CSB-EP539902SYY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella woodyi Gamma-glutamyl phosphate reductase (proA) CSB-YP539903SYY
CSB-EP539903SYY
CSB-BP539903SYY
CSB-MP539903SYY
CSB-EP539903SYY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella woodyi Probable nicotinate-nucleotide adenylyltransferase (nadD) CSB-YP539904SYY
CSB-EP539904SYY
CSB-BP539904SYY
CSB-MP539904SYY
CSB-EP539904SYY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella woodyi Sulfite reductase [NADPH] hemoprotein beta-component (cysI), partial CSB-YP539905SYY
CSB-EP539905SYY
CSB-BP539905SYY
CSB-MP539905SYY
CSB-EP539905SYY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella woodyi Cytidylate kinase (cmk) CSB-YP539906SYY
CSB-EP539906SYY
CSB-BP539906SYY
CSB-MP539906SYY
CSB-EP539906SYY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella woodyi Catalase-peroxidase (katG), partial CSB-YP539907SYY
CSB-EP539907SYY
CSB-BP539907SYY
CSB-MP539907SYY
CSB-EP539907SYY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella woodyi Lysine--tRNA ligase (lysS), partial CSB-YP539908SYY
CSB-EP539908SYY
CSB-BP539908SYY
CSB-MP539908SYY
CSB-EP539908SYY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella woodyi Protein CrcB homolog (crcB), partial CSB-YP539909SYY1
CSB-EP539909SYY1
CSB-BP539909SYY1
CSB-MP539909SYY1
CSB-EP539909SYY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>